Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.110
+0.100 (2.49%)
At close: Mar 9, 2026, 4:00 PM EDT
4.150
+0.040 (0.97%)
After-hours: Mar 9, 2026, 6:02 PM EDT
Prime Medicine Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -201.14 | -195.88 | -198.13 | -121.82 | -165.37 | |
| Depreciation & Amortization | 7.32 | 6.13 | 4.65 | 2.22 | 0.57 | |
| Loss (Gain) From Sale of Assets | - | - | 0.03 | 0.01 | - | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 12.02 | |
| Loss (Gain) From Sale of Investments | -2.37 | -2.61 | -1.03 | 7.88 | 1.11 | |
| Stock-Based Compensation | 29.27 | 26.07 | 13.91 | 6.46 | 1.75 | |
| Other Operating Activities | 9.7 | 12.36 | 12.51 | 8.83 | 84.67 | |
| Change in Accounts Payable | 1 | -5.26 | 9.14 | 2.46 | 1.19 | |
| Change in Unearned Revenue | -4.36 | 70.31 | - | - | - | |
| Change in Other Net Operating Assets | -1.98 | -33.98 | -6.49 | -37.86 | 29.99 | |
| Operating Cash Flow | -162.56 | -122.87 | -165.41 | -131.83 | -34.08 | |
| Capital Expenditures | -4.53 | -7.29 | -8.72 | -16.1 | -4.15 | |
| Investment in Securities | -104.23 | 74.75 | 27.61 | -30.34 | -68.98 | |
| Other Investing Activities | - | 1 | -0.17 | -0.67 | -0.5 | |
| Investing Cash Flow | -108.76 | 68.46 | 18.71 | -47.1 | -73.63 | |
| Issuance of Common Stock | 139.51 | 171.08 | 0.66 | 185.54 | - | |
| Other Financing Activities | 12 | 24.8 | - | -4.04 | -1.09 | |
| Financing Cash Flow | 151.51 | 195.88 | 0.66 | 181.49 | 269.28 | |
| Net Cash Flow | -119.82 | 141.47 | -146.05 | 2.57 | 161.57 | |
| Free Cash Flow | -167.1 | -130.16 | -174.14 | -147.92 | -38.23 | |
| Free Cash Flow Margin | -3607.40% | -4363.36% | - | - | - | |
| Free Cash Flow Per Share | -1.12 | -1.10 | -1.91 | -4.37 | -2.95 | |
| Levered Free Cash Flow | -85.37 | -114.57 | -96.21 | -117.62 | -6.8 | |
| Unlevered Free Cash Flow | -85.37 | -114.57 | -96.21 | -117.62 | -6.8 | |
| Change in Working Capital | -5.34 | 31.08 | 2.65 | -35.4 | 31.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.